2-28538337-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_153021.5(PLB1):c.574G>A(p.Gly192Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000546 in 1,613,160 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_153021.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLB1 | NM_153021.5 | c.574G>A | p.Gly192Ser | missense_variant | 10/58 | ENST00000327757.10 | |
PLB1 | NM_001170585.2 | c.607G>A | p.Gly203Ser | missense_variant | 10/57 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLB1 | ENST00000327757.10 | c.574G>A | p.Gly192Ser | missense_variant | 10/58 | 1 | NM_153021.5 | P1 | |
PLB1 | ENST00000422425.6 | c.607G>A | p.Gly203Ser | missense_variant | 10/57 | 1 | |||
PLB1 | ENST00000404858.5 | c.604G>A | p.Gly202Ser | missense_variant | 10/57 | 1 | |||
PLB1 | ENST00000416713.5 | c.439G>A | p.Gly147Ser | missense_variant | 10/11 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 152000Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000403 AC: 10AN: 248288Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134660
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461160Hom.: 1 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 726896
GnomAD4 genome AF: 0.0000461 AC: 7AN: 152000Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74214
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at